PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Health Aids After the initial androgen deprivation therapy (ADT), part of the prostate cancer may continuously deteriorate into castration-resistant prostate cancer (CRPC).The majority of patients suffer from the localized illness at primary diagnosis that could rapidly assault other organs.This disease stage is referred as metastatic castration-re